Orotic acid induces apoptotic death in ovarian adult granulosa tumour cells and increases mitochondrial activity in normal ovarian granulosa cells

• Published in: Reproductive biology Vol. 23; no. 3; p. 100790
• Main Authors: Marynowicz, Weronika, Borski, Norbert, Flis, Zuzanna, Ptak, Anna, Molik, Edyta
• Format: Journal Article
• Language: English
• Published: Poland Elsevier B.V 01.09.2023
• Subjects: Apoptosis; Human ovarian granulosa cells; Human ovarian granulosa tumours; Orotic acid; Proliferation; Human ovarian granulosa cells; Orotic acid; Human ovarian granulosa tumours; Proliferation; Apoptosis
• ISSN: 1642-431X; 2300-732X
• DOI: 10.1016/j.repbio.2023.100790

Orotic acid (OA) is a natural product that acts as a precursor in the pyrimidine nucleotide biosynthesis pathway. Most studies concerning administration of OA focus on its therapeutic effects; however, its effect on tumours is unclear. We aimed to determine whether treatment with OA influences the viability and apoptosis of normal (HGrC1) and tumour-derived (KGN) human ovarian granulosa cells. The effects of OA (10–250 μM) on viability and apoptosis of both cell lines were determined by using alamarBlue and assessing caspase-3/7 activity, respectively. Annexin V binding and loss of membrane integrity were evaluated in KGN cells. The cell cycle and proliferation of HGrC1 cells were assessed by performing flow cytometric and DNA content analyses, respectively. The influence of OA (10 and 100 μM) on cell cycle- and apoptosis-related gene expression was assessed by RT-qPCR in both cell lines. Mitochondrial activity was analysed by JC-1 staining in HGrC1 cells. In KGN cells, OA reduced viability and increased caspase-3/7 activity, but did not affect mRNA expression of Caspase 3, BAX, and BCL2. OA enhanced proliferation and mitochondrial activity in HGrC1 cells without activating apoptosis. This study demonstrates that the anti-cancer properties of OA in ovarian granulosa tumour cells are not related to changes in apoptosis-associated gene expression, but to increased caspase-3/7 activity. Thus, OA is a promising therapeutic agent for ovarian granulosa tumours. Further, our results suggest that differences in basal expression of cell cycle- and apoptosis-related genes between the two cell lines are responsible for their different responses to OA. •Orotic acid induces apoptotic death of human ovarian granulosa tumour (KGN) cells.•Orotic acid anti-cancer properties are not related to changes in the expression of apoptosis-associated genes.•Orotic acid enhanced proliferation and mitochondrial activity in normal (HGrC1) human ovarian granulosa cells.•HGrC1 cells and KGN have different genetic backgrounds and are differently sensitive to orotic acid treatment.